This letter is to inform the heath authorities of the ****** study (D********) results
based on the primary endpoint of Progression Free Survival (PFS). ******* was a
Phase III, double blind, placebo controlled, parallel, multi-centre study to compare the
efficacy and safety .....

Заранее Спасибо.